Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-09-22T11:55:58.153Z.
Consensus retrieved: 2026-09-13T23:56:35.719Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-22T11:55:58.153Z.
Quote observation: 2026-09-21T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c3ee83f44a2efdd70b4cb60cd726217b4474c91f0f3ed8ed7c47805bb1a8d1c9
Forward PE Ratio (N/A) = Dated Quote Price ($6.27) / Consensus Forward EPS ($-0.86)
FORWARD PE RATIO
N/A
Teladoc Health, Inc.
Market Cap
$1.14B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.14B | N/A |
| NRC Health (NRC)vs › | $479.36M | 24.17 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.89B | 6.17 |
| Shoulder Innovations, Inc. (SI)vs › | $363.33M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $47.08M | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.02B | 58.85 |
| Doximity, Inc. (DOCS)vs › | $5.02B | 19.94 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 19.87 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.77B | N/A |
| Chemed Corporation (CHE)vs › | $6.53B | 19.58 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $6.27, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.86 | $-0.97 – $-0.77 | 10 | n/m |
| 2027-12-31 | $-0.62 | $-0.99 – $-0.41 | 10 | n/m |
| 2028-12-31 | $-0.53 | $-1.06 – $0.32 | 9 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
